Why don't brain tumours respond to medication?
Tuesday, September 1, 2009 - 12:00
in Health & Medicine
Malignant brain tumours often fail to respond to promising new medication. Researchers in Heidelberg have discovered a mechanism and a tumour marker for the development of this resistance. A 'death receptor' can possibly provide information as to how great the chances of success are for chemotherapy. At the same time, it offers a new approach for promising brain tumour therapy...